1 |
Wenk GL, Stoehr JD, Quintana. G, Mobley S, Wiley RG. Behaviorall, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. J Neurosci 1994, 14, 5986-5995
DOI
|
2 |
Bartus RT, Dean RL 3rd, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982, 217, 408-414
DOI
|
3 |
Bird TD, Stranahan S, Sumi SM, Raskind M. Alzhemer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups. Ann Neurol 1983, 14, 284-293
DOI
ScienceOn
|
4 |
Boncristiano S, Calhoun ME, Kelly PH, Pfeifer M, Bondolfi L, Stalder M, Phinney AL,. Abramowski D, Sturchler-Pierrat C, Enz A, Sommer B, Staufenbiel M, Jucker M. Cholinetgic changes in the APP23 transgenic mouse model of cerebral amyloidosis. J Neurosci 2002, 22, 3234-3243
DOI
|
5 |
Bronfman FC, Moechars D, Van Leaven F. Acetylcholinesterase-posilivc fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein london mutant transgenic mice. Neurobiol Dis 2000, 7, 152-168
DOI
ScienceOn
|
6 |
Chong YH, Jung JM, Choi W, Park CW, Choi KS, Suh YH. Bacterial expression, purification of full length and carboxyl terminal fragment of Alzheimer amyloid precursor protein and their proteolytic processing by thrombin. Life Sci 1994, 54, 1259-1268
DOI
ScienceOn
|
7 |
Coyle JT, Price DL, DeLong MR. Alzheimer's disease: A disorder of cortical cholinergic innervation. Science 1983, 219, 1184-1190
DOI
|
8 |
Durkin TP. GABAergic mediation of indirect transsynaptic control over basal and spatial memory testing-induced activation of septo-hippocampal cholinergic activity in mice. Behav Brain Res 1992, 50, 155-165
DOI
ScienceOn
|
9 |
Fraser SP, Suh YH, Djamgoz MBA. Ionic effects of the Alzheimer's disease precursor protein and its metabolic fragments. Trends Neurosci 1997, 20, 67-72
DOI
ScienceOn
|
10 |
Gaykema RP, Luiten PG, Nyakas C, Traber J. Cortical projection patterns of the medial septumdiagonal band complex. J Comp Neurol 1990, 293, 103-124
DOI
ScienceOn
|
11 |
Gaykema RP, Nyakas C, Horvath E, Hersb LB, Majtenyi C, Luiten PG. Cholinergic fiber aberrations in nucleus basalis lesioned rat and Alzheimer's disease. Neurobiol Aging 1992, 13, 441-448
DOI
ScienceOn
|
12 |
Itoh A, Nitta A, Nadai M, Nishimura K, Hirose M. Hasegawa T, Nabeshima T. Dysfunction of cholinergic and dopaminergic neuronal systems in betaamyloid protein-infused rats. J Neurochem 1996, 66, 1113-1117
DOI
|
13 |
Johnson DA, Zambon NJ, Gibbs RB. Selective lesion of cholinergic neurons in the medial septum by 192 IgG-saporin impairs learning in a delayed matching to position T-maze paradigm. Brain Res 2002, 943, 132-141
DOI
ScienceOn
|
14 |
Lang W, Henke H. Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients. Brain Res 1983, 267, 271-280
DOI
ScienceOn
|
15 |
Maruyama K, Terakado K, Usami M, Yoshikawa K, Formation of amyloid-like fibrils in COS cells overexpressing part of the Alzheimer amyloid protein precursor. Nature 1990, 347, 566-569
DOI
ScienceOn
|
16 |
Yamad. K, Taoaka T, Han D, Stnzaki K, Kameyama T, Nabeshima T. Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo. Eur J Neurosci 1999, 11, 83-90
DOI
|
17 |
McKinney M, Coyle JT, Hedreen JC. Topographic analysis of the innervalion of the rat neorortex and hippocampus by the basal forebrain cholinergic system. J Comp Neurol 1983, 217, 103-121
DOI
ScienceOn
|
18 |
Minger SL, Esiri MM, McDonald B, Keene J, Carter J, Hope T, Francis PT. Cholinergic deficits contribute to behaviorai disturbance in patients with dementia. Neurology 2000, 55, 1460-1467
DOI
ScienceOn
|
19 |
Nalbantoglu J, Tirado-Sanriago G, Lahsaini A, Poirier J , Goncalves O, Verge G, Momoli F, Welner SA, Massicotte G, Julien JP, Shapiro MLL. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 1997, 387, 500-505
DOI
ScienceOn
|
20 |
Yamaguchi Y, Matsuno T, Kawashima S. Antiamnesic effects of azaindolizinone derivative ZSET845 on impaired learning and decrreased ChAT activity induced by amyloid-beta 25-35 in the rat. Brain Res 2002, 945, 259-265
DOI
ScienceOn
|
21 |
Soininen H, Kosunen O, Helisalmi S, Mannermaa A, Paljarvi L, Talasoiemi S, Ryynanen M, Riekkinen P Sr. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele. Neurosci Lett 1995, 187, 79-82
DOI
ScienceOn
|
22 |
Nakamura S, Murayaml N, Noshita T, Annoura, H, Ohno T. Progressivc brain dyfunction following intracerebroventricular infusion of beta(1-42)-amyloid peptide. Brain Res 2001, 912, 128-136
DOI
ScienceOn
|
23 |
Yankner BA, Dawes LR, Fisher S, Villa.-Komaroff L, Osler-Cranite ML, Neve RL. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 1989, 245, 417-420
DOI
|
24 |
Fadda F, Cocco S, Stancampiano R. Hippocampal acetylcholine release correlates with spatial learning performance in freely moving rats. Neuroreport 2000, 11, 2265-2269
DOI
ScienceOn
|
25 |
Sub YH. An etiological role of amyloidogenic carboxyl-terminal fragments of the beta-amyloid precursor protein in Alzheimer's disease. J Neurochem 1997, 68, 1781-1791
DOI
ScienceOn
|
26 |
Kar S, Issa AM, Seto D, Auld DS, Collier B. Quirion R. Amyloid beta-peptide inhibits high-affinity cholineuplake and acetylcholine release in rat hippocampal slices. J Neurochem 1998, 70, 2179-2187
DOI
ScienceOn
|
27 |
Yamada K, Tanaka T, Mamiya. T, Sbiotani T, Kamyama T, Nabeshima T. Improvement by nefiracctam of beta-amyloid-(1-42)-induced learning and memory impairments in rats. Br J Pharmacol 1999, 126, 235-244
DOI
ScienceOn
|
28 |
Baskin DS, Browning JL, Pirozzolo FJ, Korporaal S, Baskin JA, Appel SH. Brain choline acetyltransferase and mental function in Alzheimer disease. Arch Neurol 1999, 56, 1121-1123
DOI
ScienceOn
|
29 |
Matsumoto A, Fujiwara Y. Abnormal and deficient processing of beta-amyloid precursor protein in familial Alzheimer's disease Iymphoblastoid cells. Biochem Biophys Res Commun 1991, 175, 361-365
DOI
ScienceOn
|
30 |
Rossor MN, Iversen LL, Reynolds GP, Mountjoy CQ, Roth M. Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J (Clin Res Ed) 1984, 288, 961-964
DOI
|
31 |
Song DK, Won MH, Jung JS, Lee JC, Kang TC, Suh HW, Huh SO, Paek SH, Kim YH, Kim SH, Suh YH. Behaviral and neuropathologic changes indueed by central injection of carboxyl-terminal fragment of beta-amyloid precursor protein in mice. J Neurochem 1998, 71, 875-878
DOI
ScienceOn
|
32 |
Giacobini E. From molecular structure to Alzheimer therapy. Jpn J Pharmacol 1997, 74, 225-241
DOI
|
33 |
Kitt CA, Hohmann C, Coyle JT, Price DL. Cholinergic innervation of mouse forebrain structures. J Comp Neurol 1994, 341, 117-129
DOI
ScienceOn
|
34 |
Choi SH, Park CH, Koo JW, Seo JH, Kim HS, Jeoog SJ, Lee JH, Kim SS. Suh YH. Memory impairment and cholinergic dysfunction by centrally administered Abeta and carboxyl-terminal fragment of Alzheimer's APP in mice, FASEB J 2001, 15, 1816-1818
DOI
|
35 |
Chrobak JJ, Napier TC. Intraseptal administration of bicuculline produces working memory impairments in the rat. Behav Neural Biol 1991, 55, 247-254
DOI
ScienceOn
|
36 |
Henke H, Lang W. Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients. Brain Res 1983, 267, 281-291
DOI
ScienceOn
|
37 |
Ikonen S, Schmidt B, Rickkinen P Jr. Apamin improves spatial navigation in medial septal-Iesioned mice. Eur J Pharmacol 1998, 347, 13-21
DOI
ScienceOn
|
38 |
Marston HM, West HL., Wilkinson LS. Everittt BJ, Robbins TW. Effects of excilotoxic lesions of the septum and vertical limb nucleus of the diagonal band of Broca on condilional visual discrimination: relationship between performance and choline acetyltransferase activity in the cingulate cortex. J Neurosci 1994, 14, 2009-2019
DOI
|
39 |
Kim HS, Park. CH, Cha SH, Lee JH, Lee S, Kim Y, Rah JC, Jeong SJ, Suh YH. Carboxyl-terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity. FASEB J 2000, 14, 1508-1517
DOI
ScienceOn
|
40 |
Gilmor ML, Counts SE, Wley RG, Levey AI. Coordinate expression of the vesicular acetylcholine transporter and choline acetyltransferase following septohippocampal pathway lesions. J Neurochem 1998, 71, 2411-2420
DOI
|
41 |
Senut MC, Menecrey D, Lamour Y. Cholinergic and peptidergic projections from the medial septum and the nucleus of the diagonal band of Broca to dorsal hippocampus, cingulate cortex and olfactory bulb: a combined wheatgerm aggIutinir-apohorseradish peroxidasegold immunohistochemical study. Neuroscience 1989, 30, 385-403
DOI
ScienceOn
|
42 |
Kim SH, Sub YH. Neurotoxicity of a carboxylteminal fragment of the Alzheimer's amyloid precursor protein. J Neurochem 1996. 67, 1172-1182
DOI
ScienceOn
|
43 |
Johnson DL, Kesner RP. The effects of lesions of the entorhinal cortex and the horizontal nucleus of the diagonal band of broca upon performance of a spatial location recognition task. Behav Brain Res 1994, 61, 1-8
DOI
ScienceOn
|
44 |
Emerich DF, Walsh TJ. Ganglioside AGF2 prevents the cognitive impainnents and cholinergic cell loss following intraventricular colchicine. Exp Neurol 1991, 112, 328-337
DOI
ScienceOn
|
45 |
Zhao B, Sisodil SS, Kusilk JW. Altered processing of a mutant amyloid precursor protein in neuronal and endothelial cells. J Neurosci Res 1995, 40, 261-268
DOI
ScienceOn
|
46 |
Cummings JL, Kaufer D. Neuropsychiatric aspects of Alzheimer's disease: The cholinergic hypothesis revisited. Neurology 1996, 47, 876-883
DOI
ScienceOn
|
47 |
Kim HS, Lee JH, Suh YH. C-terminal fragment of Alzheimer's amyloid precursor protein inhibits sodium/ calcium exchanger activity in SK-N-SH cell. Neuroreport 1999, 10, 113-116
DOI
ScienceOn
|
48 |
Perry EK. The cholinergic hypothesis-ten years on. Br Med Bull. 1986, 42, 63-69
DOI
|
49 |
Glenoer GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984, 120, 885-890
DOI
ScienceOn
|
50 |
Kasa P, Rakonczay Z. Gulya K. The cholinergic system in Alzheimer's disease. Prog Neurobiol 1997, 52, 511-535
DOI
|
51 |
Lapchak PA, Jenden DJ, Herfti F. Compensatory elevation of acetylcholine synthesis in vivo by cholinergic neurons surviving panial lesions of the septohippocampal pathway. J Neurosci 1991, 11, 2821-2828
DOI
|
52 |
Lee JP, Chang KA, Kim HS, Kim SS. Jeoog SJ, Suh YH. APP carboxyl-teminal fragment without or with abeta domain equally induces cytotoxicity in differentiated PC12 cells and conical neurons. J Neurosci Res 2000, 60, 565-570
DOI
ScienceOn
|
53 |
Suh YH, Checler F. Amyloid precursor protein, presenilins, and alpna-synuclein: molecular pathogenesis and pharmacologicaI applications in Alzheimet's disease. Pharmacol Rev 2002, 54, 469-525
DOI
ScienceOn
|
54 |
Beacb TG, Kuo YM, Spiegel K, Emmerling MR, Sue LI, Kokjobn K, Rober AE. The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer disease. J Neuropathol Exp Neurol 2000, 59, 308-313
DOI
|
55 |
Kim JH, Rab JC. Fraser SP, Cbang KA, Djamgoz MBA, Suh YH. Carboxyl-terminal peptide of betaamyloid precursor protein blocks inositol 1,4,5- trisphosphate-sensitive release in Xenopus laevis oocytes. J Biol Chem 2002, 277, 20256-20263
DOI
ScienceOn
|